Adherium Ltd
ASX:ADR
Relative Value
The Relative Value of one ADR stock under the Base Case scenario is 0.15 AUD. Compared to the current market price of 0.019 AUD, Adherium Ltd is Undervalued by 87%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ADR Competitors Multiples
Adherium Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
NZ |
Adherium Ltd
ASX:ADR
|
13.6m AUD | 3.4 | -1.6 | -1.2 | -1.2 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.5B USD | 13.7 | 61.8 | 61.6 | 66.3 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.9B AUD | 81.1 | 170.1 | 117 | 117 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.9 | -351 | -186.1 | -173 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.7 | 32.9 | 22 | 23.5 | ||
SE |
Sectra AB
STO:SECT B
|
42B SEK | 25.6 | 98.9 | -65.1 | -65.1 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.9 | 25.9 | 275.5 | ||
US |
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.9 | -50.9 | 46.1 | 461.9 |